ACAD: ACADIA Pharmaceuticals Quarterly Revenue Growth

ACADIA Pharmaceuticals (ACAD) - corporate logo

ACADIA Pharmaceuticals revenues rely on exclusive rights in the therapy of CNS disorders. Quarterly revenue growth rates visualize the dynamics of this process, where 22.80 determines the current status of the parameter. The company monetizes a drug for Parkinson's disease psychosis while expanding into the Rett syndrome niche. The implementation of robotic high-throughput molecule screening significantly accelerates the conduct of preclinical research.

ACAD ACADIA Pharmaceuticals Inc Quarterly Revenue Increase (07/04/2022 - 11/20/2026)

Summary analytical data breakdowns for ACADIA Pharmaceuticals Inc. (ACAD)

- stock price and consensus target price:
Initial company analysis:ACADIA Pharma (ACAD)
Manufactured products of acadia-pharm.com

Quarterly revenue growth measures the dynamics of operating income, allowing for an assessment of the business's adaptation speed to macroeconomic cooling and the cost of debt service. The current quarterly revenue growth rate of 22.80 serves as an indicator of the commercialization efficiency of the drug Daybue, reflecting the actual success of expanding market indications and the level of insurance coverage within the neurological segment of ACADIA Pharmaceuticals (ACAD).

Main competitors

BIIB - Revenue Growth QoQ|NBIX (Neurocrine Biosciences) - Sales Growth QoQ|RGC: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Axsome (AXSM)|Revenue Growth QoQ Xenon Corp|VKTX: Quarterly Revenue Increase|Quarterly Revenue Growth SUPN|Quarterly Revenue Growth catalystpharma.com (CPRX)|Revenue Growth QoQ Denali Therapeutics DNLI|HRMY - Quarterly Sales Growth|Biohaven Pharmaceutical - Quarterly Revenue Growth|Amylyx (AMLX) - Quarterly Sales Growth|TRVI (Trevi Pharma) - Quarterly Sales Growth|Quarterly Revenue Growth Rate praxismedicines.com (PRAX)|AVXL (Anavex Life Sciences Corp) - Quarterly Revenue Growth|Revenue Growth QoQ CBLL|Quarterly Sales Growth PRTA (prothena.com)|Alector - Sales Growth QoQ|Quarterly Revenue Growth ANNX (Annexon Biosciences)|OMER: Sales Growth QoQ|NGNE - Revenue Growth QoQ|ACIU - Quarterly Revenue Growth|Voyager Corp (VYGR) - Revenue Growth QoQ|NMRA - Quarterly Sales Growth Rate|Revenue Growth QoQ Scilex|TVGN (Tevogen Bio) - Sales Change QoQ|Quarterly Sales Growth ACOG (alphacognition.com)|Quarterly Sales Growth Rate Cognition Therapeutics, Inc.|Quarterly Revenue Growth IKT (Inhibikase Pharma)|Quarterly Revenue Growth Cassava Sciences, Inc. SAVA|ASRT - Revenue Growth QoQ|Quarterly Revenue Growth Rate Coya Therapeutics Inc|Vistagen Therapeutics (VTGN) - Revenue Growth QoQ|OVID - Quarterly Sales Growth Rate|Revenue Growth QoQ Acumen Pharmaceuticals, Inc|Revenue Growth QoQ CRVO|Quarterly Revenue Growth ATHE|Clene - Sales Growth QoQ|Quarterly Revenue Growth PEPG (pepgen.com)|JUNS: Sales Growth QoQ|RLMD - Revenue Growth QoQ|Quarterly Revenue Growth Rate Annovis Bio, Inc.|GRCE (Grace Therapeutics) - Quarterly Sales Growth|Quarterly Revenue Growth Rate Firefly Neuroscience (AIFF)|Quarterly Sales Growth KLTO|NRSN: Quarterly Revenue Increase|Revenue Growth QoQ Reviva Pharmaceuticals Holdings (RVPH)|Quarterly Sales Growth MetaVia, Inc. MTVA|Revenue Growth QoQ NeurAxis NRXS|HSDT: Sales Growth QoQ|passagebio.com - Quarterly Revenue Growth|NEUP - Quarterly Revenue Growth|Minerva Neurosciences Corp (NERV) - Revenue Growth QoQ|Revenue Dynamics QoQ ATHA (Athira)|ADXN (Addex Therapeutics Ltd.) - Quarterly Revenue Growth|Sales Growth QoQ ALZN (Alzamend Neuro)|Revenue Growth QoQ Cyclerion Therapeutics Inc. (CYCN)|Quarterly Revenue Growth Protagenic Therapeutics, Inc. (PTIX)|Quarterly Revenue Growth KTTA (Pasithea Therapeutics Corp)|CRGT - Quarterly Sales Growth|ATXI - Revenue Growth QoQ|BCLI: Revenue Growth QoQ|Cara Therapeutics (CARA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Chromocell Therapeutics Corp (CHRO)|Quarterly Sales Growth ELYM|Quarterly Revenue Growth Rate intracellulartherapies.com ITCI|Revenue Growth QoQ Longboard Pharmaceuticals (LBPH)|MRNS (Marinus Pharmaceuticals) - Quarterly Revenue Increase|Revenue Growth QoQ NKGen NKGN|Quarterly Revenue Growth NeuroBo Pharmaceuticals Inc NRBO|SAGE: Quarterly Sales Growth|Quarterly Sales Growth Rate Synaptogenix, Inc SNPX|TRVN: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Vigil Neuroscience (VIGL)|Revenue Growth QoQ Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Sales Change QoQ